Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Etoposide Doxorubicin Cisplatin

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   

bladder symptoms1 - urogenital diaphragm1 - intravenous injection1 - fsgs2 - dietary phosphate2 - retrograde pyelography4 - klotho deficiency1 - active surveillance1 - acute abdomen1 - anti-neutrophil cytoplasmic antibody-associated vasculitis1 - uterine leiomyoma1 - urinary protein1 - pelvic floor4 - rheumatoid arthritis2 - spop gene1 - egfr1 - matrix calculus3 - hypertensive nephropathy1 - renal transplantation3 - autosomal dominant fsgs1 - fresenius1 - metastatic tumours1 - bladder defects1 - urinary function1 - kidney research1 - libido1 - prostate mri guidelines1 - prognostic indicator1 - generalized edema1 - tumor metabolism1 -